Breast cancer drug hope

Therapy slows disease's progression

- STORM NEWTON

A COCKTAIL of drugs targeting breast cancer could double the amount of time patients live without the disease progressing.

Researchers have branded the breakthrough as potentially transformative for those with a common form of advanced, aggressive breast cancer.

Some 325 patients from 28 countries took part in a drug trial. More than half had cancer that had spread to three or more organs, while over 80% had hemotherapy.

A total of 161 patients were given the three-drug therapy, which comprised two targeted drugs palbociclib, a type of cancer growth blocker, and a new drug called inavolisib.